Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
作者:
Antonio José,Cabrera-Serrano [1]
;
José Manuel,Sánchez-Maldonado [2]
;
Rob,Ter Horst [1]
;
Angelica,Macauda [2]
;
Paloma,García-Martín [3]
;
Yolanda,Benavente [4]
;
Stefano,Landi [5]
;
Alyssa,Clay-Gilmour [6]
;
Yasmeen,Niazi [7]
;
Blanca,Espinet [8]
;
Juan José,Rodríguez-Sevilla [9]
;
Eva María,Pérez [10]
;
Rossana,Maffei [11]
;
Gonzalo,Blanco [12]
;
Matteo,Giaccherini [13]
;
James R,Cerhan [14]
;
Roberto,Marasca [15]
;
Miguel Ángel,López-Nevot [5]
;
Tzu,Chen-Liang [16]
;
Hauke,Thomsen [13]
;
Irene,Gámez [14]
;
Daniele,Campa [9]
;
Víctor,Moreno [17]
;
Silvia,de Sanjosé [16]
;
Rafael,Marcos-Gragera [18]
;
María,García-Álvarez [19]
;
Trinidad,Dierssen-Sotos [20]
;
Andrés,Jerez [19]
;
Aleksandra,Butrym [9]
;
Aaron D,Norman [6]
;
Mario,Luppi [21]
;
Susan L,Slager [22]
;
Kari,Hemminki [6]
;
Yang,Li [7]
;
Sonja I,Berndt [7]
;
Delphine,Casabonne [23]
;
Miguel,Alcoceba [24]
;
Anna,Puiggros [25]
;
Mihai G,Netea [26]
;
Asta,Försti [7]
;
Federico,Canzian [27]
;
Juan,Sainz [28]
作者单位:
Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain.
[1]
Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain.
[2]
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
[3]
Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
[4]
Hospital Campus de la Salud, PTS, 18016 Granada, Spain.
[5]
Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
[6]
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain.
[7]
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
[8]
Department of Biology, University of Pisa, 56126 Pisa, Italy.
[9]
Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, SC 29208, USA.
[10]
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
[11]
Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
[12]
Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
[13]
Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
[14]
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
[15]
Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy.
[16]
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
[17]
Immunology Department, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
[18]
Hematology Department, Morales Meseguer University Hospital, 30008 Murcia, Spain.
[19]
MSB Medical School Berlin, D-14197 Berlin, Germany.
[20]
Cancer Prevention and Control Program, Unit of Biomarkers and Susceptibility, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, 08907 Barcelona, Spain.
[21]
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain.
[22]
Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), 17190 Girona, Spain.
[23]
Department of Nursing, Universitat de Girona, 17007 Girona, Spain.
[24]
Josep Carreras Leukemia Research Institute, 08916 Girona, Spain.
[25]
Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
[26]
Faculty of Medicine, University of Cantabria, 39011 Santander, Spain.
[27]
Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, 08035 Barcelona, Spain.
[28]
Department of Cancer Prevention and Therapy, Medical University of Wrocław, 50-556 Wrocław, Poland.
[29]
Division of Computational Genomics, Mayo Clinic, Rochester, MN 85054, USA.
[30]
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
[31]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
[32]
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic.
[33]
Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
[34]
Centre for Individualised Infection Medicine (CiiM) & TWINCORE, Joint Ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany.
[35]
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
[36]
Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany.
[37]
Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada (UGR), 18012 Granada, Spain.
[38]
主题词
成年人(Adult);人类(Humans);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);全基因组关联研究(Genome-Wide Association Study);危险因素(Risk Factors);疾病恶化(Disease Progression);疾病遗传易感性(Genetic Predisposition to Disease);多态性, 单核苷酸(Polymorphism, Single Nucleotide)
DOI
10.3390/ijms24098005
PMID
37175717
发布时间
2023-11-27
- 浏览0

International journal of molecular sciences
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文